Literature DB >> 32840578

The impact of cell maturation and tissue microenvironments on the expression of endosomal Toll-like receptors in monocytes and macrophages.

Ryota Sato1, Tatjana Reuter1,2, Ryosuke Hiranuma1, Takuma Shibata1, Ryutaro Fukui1, Yuji Motoi1, Yusuke Murakami1, Hiroki Tsukamoto3,4, Satoshi Yamazaki5, Kaiwen Liu1, Shin-Ichiroh Saitoh1, Eicke Latz2,6,7, Kensuke Miyake1.   

Abstract

Toll-like receptors (TLRs) impact myeloid cell responsiveness to environmental cues such as pathogen components and metabolites. Although TLR protein expression in monocytes and tissue macrophages is thought to be optimized for microenvironments in each tissue, a comprehensive study has not been reported. We here examined protein expression of endogenous TLRs in tissue-resident myeloid cells. Neutrophils in peripheral blood, spleen, liver and lung expressed TLR2, TLR4 and TLR5 in all tissues. Ly6C+ MHC II‒ classical monocytes mature into Ly6C‒ MHC II+ monocyte-derived dendritic cells (moDCs) or Ly6C‒ MHC II‒ patrolling monocytes. These subsets were found in all the tissues studied. TLR2 and TLR4 were displayed on all of these subsets, regardless of location. In contrast, expression of endosomal TLRs did vary with tissues and subsets. moDCs expressed TLR9, but much less TLR7. In contrast, TLR7, not TLR3 or TLR9, was highly expressed in classical and patrolling monocytes. Tissue macrophages such as red pulp macrophages in the spleen, Kupffer cells in the liver, microglia in the brain, alveolar macrophages in the lung and adipose tissue macrophages all expressed TLR2, TLR4 and TLR3. TLR7 was also expressed in these tissue macrophages except Kupffer cells in the liver. TLR9 expression in tissue macrophages was much lower or hard to detect. These results suggest that expression of endosomal TLRs in myeloid cells is influenced by their differentiation status and tissue-specific microenvironments. © The Japanese Society for Immunology. 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Toll-like receptor; innate immunity; macrophage

Year:  2020        PMID: 32840578     DOI: 10.1093/intimm/dxaa055

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  6 in total

Review 1.  Nucleic Acid Sensing by Toll-Like Receptors in the Endosomal Compartment.

Authors:  Kensuke Miyake; Takuma Shibata; Ryutaro Fukui; Ryota Sato; Shin-Ichiroh Saitoh; Yusuke Murakami
Journal:  Front Immunol       Date:  2022-06-23       Impact factor: 8.786

Review 2.  Strategies for Biomaterial-Based Spinal Cord Injury Repair via the TLR4-NF-κB Signaling Pathway.

Authors:  Bin Lv; Naiting Shen; Zhangrong Cheng; Yuhang Chen; Hua Ding; Jishan Yuan; Kangchen Zhao; Yukun Zhang
Journal:  Front Bioeng Biotechnol       Date:  2022-04-29

Review 3.  TLR9 in MAFLD and NASH: At the Intersection of Inflammation and Metabolism.

Authors:  Christopher R Shepard
Journal:  Front Endocrinol (Lausanne)       Date:  2021-01-29       Impact factor: 5.555

4.  Anti-TLR7 Antibody Protects Against Lupus Nephritis in NZBWF1 Mice by Targeting B Cells and Patrolling Monocytes.

Authors:  Yusuke Murakami; Ryutaro Fukui; Reika Tanaka; Yuji Motoi; Atsuo Kanno; Ryota Sato; Kiyoshi Yamaguchi; Hirofumi Amano; Yoichi Furukawa; Hitoshi Suzuki; Yusuke Suzuki; Naoto Tamura; Naomi Yamashita; Kensuke Miyake
Journal:  Front Immunol       Date:  2021-11-11       Impact factor: 7.561

5.  Isthmin 1 is Expressed by Progenitor-Like Cells in the Lung: Phenotypical Analysis of Isthmin 1+ Hematopoietic Stem-Like Cells in Homeostasis and during Infection.

Authors:  Guadalupe Rivera-Torruco; Carolina A Martínez-Mendiola; Tania Angeles-Floriano; Gustavo Alberto Jaimes-Ortega; José Luis Maravillas-Montero; Rodolfo García-Contreras; Yolanda González; Esmeralda Juárez; Porfirio Nava; Vianney Ortiz-Navarrete; Oscar Medina-Contreras; Paula Licona-Limón; Ricardo Valle-Rios
Journal:  J Immunol Res       Date:  2022-04-01       Impact factor: 4.818

Review 6.  Herbal Medicine, Gut Microbiota, and COVID-19.

Authors:  Ziqi Chen; Yiwen Lv; Huachong Xu; Li Deng
Journal:  Front Pharmacol       Date:  2021-07-07       Impact factor: 5.988

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.